+612 9045 4394
 
CHECKOUT
$7.95 Delivery per order to Australia and New Zealand
100% Australian owned
Over a hundred thousand in-stock titles ready to ship
Screening for Biological Response Modifiers : Methods and Rationale - J.E. Talmadge

Screening for Biological Response Modifiers

Methods and Rationale

Hardcover Published: 30th April 1985
ISBN: 9780898387124
Number Of Pages: 194

Share This Book:

Hardcover

$236.87
or 4 easy payments of $59.22 with Learn more
Ships in 15 business days

Earn 474 Qantas Points
on this Book

Other Available Editions (Hide)

  • Paperback View Product Published: 18th November 2011
    Ships in 15 business days
    $213.24

The observation in the 1950s that nitrogen mustard and other toxic chemicals could induce antitumor responses in patients with refractory lymphoma initiated a massive search for active chemotherapeutic agents. The initial observations stimulated a search for new chemotherapeutic agents which might have increased antitumor activity with less toxicity for normal tissues. To aid in the search for these new chemicals and to attempt to distinguish among the many toxic chemicals which might be candidates for clinical studies, the National Cancer Institute, the pharmaceutical industry, and the cancer research laboratories of most Western nations developed systems for "screening" drugs for antitumor activity. Perhaps the most extensive screening program was established by the National Cancer Institute (1). This screening program has evolved over the last two decades, an evolution which has been repeatedly reviewed (2-5). Various screening programs in use have examined over 500,000 compounds as potential anticancer agents. From these, there are now approximately forty anticancer drugs in clinical use. The utiliy of these compounds and their toxicities have been reviewed on many occasions. It is now apparent that more active and less toxic anticancer drugs are needed. It is also clear that the current screening programs are identifying compounds with similar levels of activity and with continuing moderate to severe toxicity (6).

1. Biologic and Technical Considerations for the Design of Screening Procedures for the Assessment of Biological Response Modifiers.- 2. Procedures for Preclinical Screening of Biological Response Modifying Agents.- 3. Preclinical Evaluation of Individual Biological Response Modifiers.- 4. Clinical Correlations.

ISBN: 9780898387124
ISBN-10: 0898387124
Series: Developments in Oncology
Audience: General
Format: Hardcover
Language: English
Number Of Pages: 194
Published: 30th April 1985
Publisher: SPRINGER VERLAG GMBH
Country of Publication: US
Dimensions (cm): 23.83 x 16.56  x 1.91
Weight (kg): 0.49

Earn 474 Qantas Points
on this Book